Sign in

    Robert A. Berman

    Chief Executive Officer at enVVeno Medical Corp
    Board
    Since April 30, 2018
    Age
    62 years
    Education
    Holds a B.S. in Entrepreneurial Management from the Wharton School of the University of Pennsylvania and a J.D. from Northwestern University School of Law.
    Tenure
    Joined NVNO as Chief Executive Officer and Board member in April 2018 and has overseen strategic transitions since then.

    Also at enVVeno Medical Corp

    CG
    Craig Glynn
    Chief Financial Officer and Treasurer
    DHA
    Dr. Hamed Alavi
    Senior Vice President and Chief Technology Officer
    MHG
    Marc H. Glickman
    Senior Vice President and Chief Medical Officer

    About

    Robert A. Berman is an experienced executive with over 25 years in healthcare, finance, and technology, and is currently 62 years old as per the latest reports.

    Before joining NVNO, he held senior leadership roles at Acacia Research Corporation and ITUS Corporation, where he played key roles in transforming business strategies and operational frameworks.

    Since his appointment in April 2018, and specifically as Chief Executive Officer from April 30, 2018, he has managed risk oversight, corporate strategy, and significant operational reforms, further extending his influence through academia as an adjunct faculty member.

    $NVNO Performance Under Robert A. Berman

    Past Roles

    OrganizationRoleDate RangeDetails
    ITUS Corporation (now Anixa Biosciences) President, Chief Executive Officer, and Board Director September 2012 - July 2017 Transitioned the company from a flat panel display developer to a Nasdaq-listed cancer therapeutics company
    Acacia Research Corporation Chief Operating Officer and General Counsel 2000 - March 2007 Transitioned the company from an incubator of internet startups to a publicly traded company with market capitalization exceeding $2 billion
    Blank Rome Early Career Role N/A Started his career at this law firm

    External Roles

    OrganizationRoleDate RangeDetails
    Northwestern University School of Law Adjunct Faculty Member N/A Holds an adjunct position at the School of Law

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Salary $500,000 Annual (Fiscal Year Ended Dec 31, 2024)Fixed annual salary
    Option Awards $400,513 Vests quarterly over 3 years200,000 stock options granted on Dec 18, 2024; computed per FASB ASC Topic 718
    Other Compensation $28,119 AnnualIncludes company-paid healthcare of $9,679 and a 401(k) match of $18,441

    Performance Compensation

    Data from  FY 2024

    Bonus

    MetricValue
    Amount ($USD) $232,500
    Eligible as (% of Base Salary) Up to 60%
    Performance Metrics Key Performance Indicators (KPI); specifics not disclosed
    Evaluation Period Fiscal 2024
    Payout Timing Annual

    Restricted Stock Units (RSUs)

    MetricValue
    Number of RSUs 200,000
    Market Value as of 12/31/2024 ($USD) $604,000
    Performance Requirement Pre-Market Approval of the VenoValve
    Vesting Condition Entire lot vests upon achieving the milestone
    Additional Details SAVVE condition removed on 12/05/2023; RSUs originally subject to dual milestones